Atherogenic lipoproteins enhance mesangial cell expression of platelet-derived growth factor: Role of protein tyrosine kinase and cyclic AMP-dependent protein kinase A

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 5, 1998, Pages 456-465

  Ha, Hunjoo ^b   Roh, Daeyoung D ^b   Kirschenbaum, Michael A ^b   Kamanna, Vaijinath S ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032078230     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90147-0     Document Type: Article

References (55)

1. Floege J, Eng E, Young BA, et al. Infusion of PDGF or basic FGF induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 1993;92:2952-62.
2. Coffey AK, Karnovsky MJ. Haparin inhibits mesangial cell proliferation in Habu-venum induced glomerular injury. Am J Pathol 1985;120:248-55.
3. Johnson RJ, Raines EW, Floege J, et al. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992;175:1413-6.
4. Tang WW, Wilson CB. Heparin decreases mesangial matrix accumulation after selective antibody-induced mesangial cell injury. J Am Soc Nephrol 1992;3:921-9.
5. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin inhibits mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 1993;43:369-80.
6. Diamond J, Karnovsky MJ. Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Renal Physiol 1986;9:366-74.
7. Purkerson ML, Tollefsen DM, Klahr S. N-desulfate/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 1988;81:69-74.
8. Eng E, Floege J, Young BA, Couser WG, Johnson RJ. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? Kidney Int Suppl 1994;45:45-7.
9. Abboud HE. Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 1995;57:297-309.
10. Schultz PJ, Dicorleto PE, Silver BJ, Abboud HE. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 1988;255:F674-84.
11. Isaka Y, Fujiwara Y, Ueda N, Kaceda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into rat kidney. J Clin Invest 1993;92:2597-601.
12. Maeshima Y, Kashihara N, Sugiyama H, et al. Inhibition of mesangial cell proliferation and matrix expansion by antisense oligonucleotides targeting platelet derived growth factor and transforming growth factor-β mRNA in vivo. J Am Soc Nephrol 1994;5:835A.
13. Avram MM. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy. Am J Med 1989;87:39N-41.
14. Appel G. Lipid abnormalities in renal disease. Kidney Int 1991;39:169-83.
15. Kamanna VS, Roh DD, Kirschenbaum MA. Atherogenic lipoproteins: mediators of glomerular injury. Am J Nephrol 1993;13:1-5.
16. Diamond JR, Karnovsky MJ. Focal segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988;33:917-24.
17. Kamanna VS, Lee DM. Rat apolipoprotein B differs in solubility properties from human apolipoprotein B. Biochim Biophys Acta 1990;143:119-21.
18. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34:1345-53.
19. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-6.
20. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 1984;81:3883-7.
21. Grone EF, Abboud HE, Hohne M, et al. Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors. Am J Physiol 1992;263:F686-96.
22. Coritsidis G, Rifici V, Gupta S, et al. Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 1991;39:858-66.
23. Wheeler D, Chana R, Topley H, Peterson M, Davies M, Williams J. Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 1994;45:1628-36.
24. Keane WF, O'Donnell MP, Kasiske BL, Kim Y. Oxidative modification of low density lipoproteins by mesangial cells. J Am Soc Nephrol 1993;4:187-94.
25. Kamanna VS, Pai R, Roh DD, Kirschenbaum MA. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Lab Invest 1996;74:1067-79.
26. Lowry OH, Rosebrough NF, Farr AG, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
27. Jadus MR, Pai R, Horansky E, Wepsic HT, Kirschenbaum MA, Kamanna VS. Hematopoietic colony stimulatory factor formation by murine mesangial cells: gene expression and biological activity. Biochim Biophys Acta 1994;1224:181-8.
28. Pai R, Bassa B, Kirschenbaum MA, Kamanna VS. TNF-α stimulates monocyte adhesion to glomerular mesangial cells: the role of intercellular adhesion molecule-1 gene expression and protein kinases. J Immunol 1996;156:2571-79.
29. Akiyama T, Ogawara H. Use and specificity of genistein, an inhibitor of protein-tyrosine kinase. Methods Enzymol 1991;201:362-70.
30. Uehara Y, Fukazawa H. Use and selectivity of herbimycin A, an inhibitor of protein-tyrosine kinases. Methods Enzymol 1991;201:370-9.
31. Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1989;162:156-60.
32. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL, Striker GE. Glomerular epithelial, mesangial and endothelial cell lines from transgenic mice. Kidney Int 1988;33:677-84.
33. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein JE/MCP-1, and the monocyte colony stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. J Clin Invest 1993;92;1564-71.
34. Pai R, Kirschenbaum MA, Kamanna VS. Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells. Kidney Int 1995;48:1254-62.
35. Levitzki A, Gazit A, Osherov N, Posner I, Gilon C. Inhibition of protein-tyrostine kinases by tyrphostins. Methods Enzymol 1991;201:347-61.
36. Grone H-J, Walli AK, Grone E, et al. Induction of glomerulosclerosis: a functional and morphologic study in the rat. Lab Invest 1989;60:433-46.
37. Kasiske BL, O'Donnell MP, Schimitz PG, Kim Y, Keane WF. Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 1990;37:880-9.
38. Gushing SD, Berliner JA, Valente JA, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990;87:5134-8.
39. Kamanna VS, Pai R, Kirschenbaum MA. Role of protein kinase signaling mechanisms in atherogenic lipoprotein-mediated glomerular endothelial cell ICAM-1 expression and monocyte adhesion. J Am Soc Nephrol 1996;7:1679A.
40. Stiko-Rahm A, Hultgardh-Nilsson, A, Regnstrom J, Hamsten A, Nilsson J. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells. Arterioscl Thromb 1992;12:1099-109.
41. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest 1991;87:2253-7.
42. Scott-Burden T, Resink TJ, Hahn AWA, Bauer U, Box RJ, Buhler FR. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem 1989;264:12582-9.
43. Kamanna VS, Pai R, Bassa B, Kirschenbaum MA. Activation of mesangial cells with TNF-α stimulates M-CSF gene expression and monocyte proliferation: evidence for involvement of protein kinase C and protein tyrosine kinase. Biochim Biophys Acta 1996;1313:161-72.
44. Pai R, Ha H, Kirschenbaum MA, Kamanna VS. Role of tumor necrosis factor-α on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. J Am Soc Nephrol 1996;7:914-23.
45. Studer RK, Craven PA, Derubertis FR. Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: role of protein kinase C and transforming growth factorβ. J Lab Clin Med 1995;125:86-95.
46. Tan MS, Lee YJ, Shin SJ, Tsai JH. Regulation of heparin binding: epidermal growth factor like growth factor gene expression by LDL and oxidized-LDL in rat mesangial cells. Biochem Biophys Res Commun 1994;202:1001-8.
47. Haller H, Schaper D, Philipp S, Distler A. LDL induces surface expression of adhesion molecules ICAM-1 and ELAM on endothelial cells via activation of protein kinase C. J Am Soc Nephrol 1992;3:632A.
48. Murohara T, Scalia R, Lefer AM. Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells: possible involvement of protein kinase C and its inhibition by nitric oxide donors. Circ Res 1996;78:780-9.
49. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993;92:471-8.
50. Silver BJ, Jaffer FE, Abboud HE. Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci U S A 1989;86:1056-60.
51. Czech MP, Clairmont KB, Yagaloff KA, Corvera S. Properties and regulation of receptors for growth factors. In: Sporn MB, Roberts AB, editors. Peptide growth factors and their receptors. New York: Springer-Verlag, 1991:37-65.
52. Guevara J Jr, Walch ET, Epstein HF, Sparrow JT, Gotto AM, Valentinova NV. Evidence that apo B-100 of low density lipoproteins is a novel Src-related protein kinase. J Protein Chem 1995;14:627-31.
53. Kamanna VS, Bassa B, Kirschenbaum MA. Atherogenic lipoproteins induce mesangial cell protein tyrosine phosphorylation and activation of growth factor receptors; signal transduction mechanisms of cell proliferation. J Am Soc Nephrol 1996;7:1679A.
54. Kamanna VS, Bassa BV, Lee J, Roh DD, Kirschenbaum MA. Minimally modified LDL activates mesangial cell protein tyrosine kinase, Ras, and mitogen-activated protein kinase. J Am Soc Nephrol 1997;8:2042A.
55. Bassa B, Pai R, Ha H, Kamanna VS, Kirschenbaum MA. Activation of mesangial cell mitogen activated protein kinase cascade by atherogenic lipoproteins. J Am Soc Nephrol 1995;6:783A.